Abstract: A radio therapy system includes a first x-ray source. The first x-ray source is configured to produce first x-ray photons in a first energy range suitable for imaging and project the first x-ray photons onto an area designated for imaging. The system includes a second x-ray source configured to produce second x-ray photons in a second energy range higher energy than the first energy range, produce third x-ray photons in a third energy range higher energy than the first energy range, project the second x-ray photons onto the area designated for imaging, and project the third x-ray photons onto an area designated for treatment. The system includes an analytical portion configured to collect and combine data to create a composite output including at least one image, the combining based in part on a spectral analysis.
Type:
Grant
Filed:
June 4, 2021
Date of Patent:
May 16, 2023
Assignees:
Accuray, Inc., The University of Chicago
Inventors:
Patrick La Riviere, Daniel Gagnon, Zhicong Yu, Julian Bertini, Phillip Vargas
Abstract: Limit size lipid nanoparticles, methods for using the lipid nanoparticles, and methods and systems for making limit size lipid nanoparticles.
Type:
Grant
Filed:
October 1, 2020
Date of Patent:
May 16, 2023
Assignee:
The University of British Columbia
Inventors:
Pieter R. Cullis, Igor V. Jigaltsev, Robert James Taylor, Timothy Leaver, Andre Wild, Nathan Maurice Belliveau
Abstract: Embodiments disclosed herein facilitates the monitoring of direct ultraviolet B (UVB) radiation exposure by a person via a system having a sensor (such as Lanthanum doped lead zirconate titanate (PLZT) thin-film sensors or other ferroelectric-based sensors) sensitive to UVB radiation. The system beneficially provides current real-time dosage information associated with Vitamin D production by the person as well as real-time indication of safe exposure and/or harmful exposure to current UVB radiation conditions while also, in some embodiments, takes into consideration a person's age, skin type and sensitivity, body surface area exposed.
Type:
Grant
Filed:
January 19, 2021
Date of Patent:
May 16, 2023
Assignee:
The Board of Trustees of The University of Alabama
Abstract: The present invention provides an immunity-inducing agent comprising a polynucleotide-peptide conjugate or a pharmaceutically acceptable salt thereof as an active component, wherein the polynucleotide-peptide conjugate consists of: a single-chain polynucleotide or polynucleotide derivative comprising a CpG motif; a peptide; and a spacer which is covalently bonded at one end thereof to the polynucleotide or polynucleotide derivative and covalently bonded at the other end thereof to the peptide, wherein the peptide is a peptide modified by substituting one or more contiguous amino acids at the N-terminus of an MHC-binding peptide with an amino acid having a reactive functional group which allows for the formation of a covalent bond with the spacer, wherein the one or more contiguous amino acids contain no anchor residues for MHC binding.
Type:
Application
Filed:
March 26, 2021
Publication date:
May 11, 2023
Applicants:
The University of Kitakyushu, Daiichi Sankyo Company, Limited
Inventors:
Shinichi Mochizuki, Makoto Koizumi, Koji Morita
Abstract: An adhesion-preventing material having a high adhesion-preventing effect has been demanded. An adhesion-preventing material including a sterilized biocompatible sponge-like laminate, wherein the sponge-like laminate comprises a sponge-like first layer and a sponge-like second layer each of which is at least partially crosslinked with a curing agent and comprises a low-endotoxin alginic acid monovalent metal salt, the alginic acid monovalent metal salt in the first layer has a weight average molecular weight of 10,000 to 2,000,000, the alginic acid monovalent metal salt in the second layer has a weight average molecular weight of 1,000 to 1,000,000, the weight average molecular weights are measured by a GPC-MALS method after a decrosslinking treatment, and the weight average molecular weight of the alginic acid monovalent metal salt in the first layer is higher than that in the second layer.
Type:
Application
Filed:
August 26, 2022
Publication date:
May 11, 2023
Applicants:
Mochida Pharmaceutical Co., Ltd., The University of Tokyo
Abstract: A monitoring system according to one aspect of the present disclosure includes: a sensor to measure physical quantities at one or a plurality of measurement points of a structural body; processing circuitry configured to acquire measured values from the measurer; a memory to store the measured values acquired from the measurer; and a data storage that, when one or some of the measured values stored in the memory satisfy a predetermined trigger condition, and as a result, it is determined that the structural body has received impact, records a group of data of the measured values which are within a certain time range and include the measured value based on which it is determined that the trigger condition is satisfied.
Type:
Application
Filed:
January 13, 2023
Publication date:
May 11, 2023
Applicants:
KAWASAKI JUKOGYO KABUSHIKI KAISHA, The University of Tokyo
Inventors:
Takuya ISHIDA, Hiroshi MAMIZU, Yuji IKEDA, Shu MINAKUCHI
Abstract: Disclosed are methods, kits and cells for screening an inhibitor of association between candidate binding partners, such as for screening antagonists of amyloid peptides. The methods, kits and cells employ a reporter expression cassette and hybrid proteins. The reporter expression cassette encodes a reporter and comprises at least one DNA binding site. Each hybrid protein comprises a candidate binding partner and a component of a DNA binding protein and, upon association, form a DNA-binding complex capable of binding to the at least one binding site and inhibiting expression of the reporter. The methods, kits and cells find application, for example, in the identification of inhibitors that may be useful in treating diseases associated with protein aggregation, such as Alzheimer's Disease and Parkinson's Disease.
Abstract: This disclosure provides for engineered T cell Receptors (TCRs), cells comprising the TCRs, and methods of making and using the TCRs. The current disclosure relates to TCRs that specifically recognize gp100. Accordingly, aspects of the disclosure relate to an engineered T-cell Receptors (TCRs), nucleic acids encoding the TCRs, and cells comprising the nucleic acids and TCRs. Also provided are compositions comprising the cells, nucleic acids, or engineered TCRs of the disclosure, methods of making the cells and methods of using the embodiments of the disclosure for therapeutic treatments.
Type:
Application
Filed:
February 25, 2021
Publication date:
May 11, 2023
Applicant:
Board of Regents, The University of Texas System
Abstract: A current interrupting device includes a current limiting element on a power supply path from a predetermined power supply to a load device. The current limiting element is configured to exhibit a current limiting action when current flowing in the power supply path exceeds a first current threshold value. The current interrupting device further includes a current diversion path switch, and a controller programmed to control on and off of the current diversion path switch. The controller is programmed to switch a current diversion path switch on from an off state when it is detected that current flowing in the current limiting element is limited to a second current threshold value after the current flowing in the current limiting element has exceeded the first current threshold value, and switch the switch off again after a predetermined switched-on holding time has elapsed since the switch has been switched on.
Type:
Grant
Filed:
September 15, 2020
Date of Patent:
May 9, 2023
Assignees:
National University Corporation Saitama University, Tokyo Institute of Technology, The University of Tokyo
Abstract: The present invention sets forth new compounds that potently block activation of ABA receptors. In some aspects, these compounds can be used to enhance germination of crop seeds to stand establishment and to increase transpiration and photosynthetic yields when water is not limiting plant growth.
Type:
Grant
Filed:
June 19, 2020
Date of Patent:
May 9, 2023
Assignee:
The Regents of The University of California
Abstract: A method and system for creating hypercomplex representations of data includes, in one exemplary embodiment, at least one set of training data with associated labels or desired response values, transforming the data and labels into hypercomplex values, methods for defining hypercomplex graphs of functions, training algorithms to minimize the cost of an error function over the parameters in the graph, and methods for reading hierarchical data representations from the resulting graph. Another exemplary embodiment learns hierarchical representations from unlabeled data. The method and system, in another exemplary embodiment, may be employed for biometric identity verification by combining multimodal data collected using many sensors, including, data, for example, such as anatomical characteristics, behavioral characteristics, demographic indicators, artificial characteristics.
Type:
Grant
Filed:
August 30, 2018
Date of Patent:
May 9, 2023
Assignee:
Board of Regents, The University of Texas System
Inventors:
Aaron Benjamin Greenblatt, Sos S. Agaian
Abstract: Certain embodiments are directed to methods and compositions for treating obesity, diabetes, and/or cancer with a combination of ursolic acid and resveratrol.
Type:
Grant
Filed:
April 17, 2021
Date of Patent:
May 9, 2023
Assignee:
Board of Regents, The University of Texas System
Inventors:
Thomas J. Slaga, Jacob Junco, Huiyun Liang, Sara Reyna
Abstract: The present invention aims to provide a warming composition showing a favorable dispersion stability after long-term storage, a high warming impact, and improvement of zeolite-specific deterioration of feeling of use, and to provide an aerosol formulation containing the warming composition. This object is achieved with a warming composition containing zeolite nanoparticles having an average particle size of not more than 500 nm, wherein the temperature of the composition is rapidly increased by heat generated by hydration reaction between the zeolite and water.
Type:
Grant
Filed:
September 13, 2019
Date of Patent:
May 9, 2023
Assignees:
Toyo Aerosol Industry Co., Ltd., The University of Tokyo
Abstract: The present disclosure provides a method for screening cells, the method including a step of preparing a plurality of cells which are tagged with a first barcode nucleic acid associated with a test target and treated with the test target, a step of sorting the plurality of cells based on cellular phenotype using an imaging cell sorter, and a step of identifying the test target used to treat each cell using the first barcode nucleic acid as an indicator.
Type:
Grant
Filed:
January 12, 2021
Date of Patent:
May 9, 2023
Assignees:
ThinkCyte, Inc., The University of Tokyo, RIKEN
Abstract: A shear-thickening electrolyte solution includes a polar solvent; an electrolyte dissolved in said polar solvent; and ceramic filler dispersed in said polar solvent, said ceramic filler having an aspect ratio, length to width, of greater than 1:1 and being functionalized to provide terminal end groups that interact with the polar solvent to form a solvation layer around said ceramic filler and support the suspension of said ceramic filler in said polar solvent.
Abstract: The treatment of bacterial respiratory infections using bacterially-originating antibiotics known as pyocins. In particular, S type pyocins are administered by pulmonary administration for the treatment of such infections.
Type:
Grant
Filed:
September 22, 2015
Date of Patent:
May 9, 2023
Assignee:
The University Court of the University of Glasgow
Abstract: A telestroke eye examination accessory device, a system incorporating the same, and methods of using the same, are described. The telestroke eye examination accessory device includes eyewear having a first eye well and a second eye well, a first camera positioned within the first eye well, a second camera positioned within the second eye well, a first light array having lights in each of four different quadrants in the first eye well, and a second light array having lights in each of four different quadrants in the second eye well. The system further includes a graphical user interface useful for a practitioner using the telestroke eye examination accessory device to assess the field of vision of a patient wearing the eyewear.
Type:
Grant
Filed:
February 6, 2020
Date of Patent:
May 9, 2023
Assignee:
The University of Toledo
Inventors:
Mouhammad A. Jumaa, Syed F. Zaidi, Hisham Salahuddin
Abstract: An integrated rapid infrastructure monitoring system for identifying defects in an underlying surface, comprising: at least one actuator; and, at least one impactor operatively connected to the actuator, wherein the actuator is configured to transition the integrated rapid infrastructure monitoring system from a first configuration with at least one of a motive force and an impact bounce force of the impactor, where the impactor is located on a first side of the integrated rapid infrastructure monitoring system, to a second configuration, where the impactor is located on a second side of the integrated rapid infrastructure monitoring system.
Type:
Grant
Filed:
September 29, 2021
Date of Patent:
May 9, 2023
Assignee:
Board of Regents, The University of Texas System
Abstract: Bio-Inks and methods of using compositions comprising the bio-Inks are disclosed. 3-D tissue repair and regeneration through precise and specific formation of biodegradable tissue scaffolds in a tissue site using the bio-inks are also provided. Specific methylacrylated gelatin hydrogels (MAC) and methacrylated chitosan (MACh) preparations formulated with sucrose, a silicate-containing component (such as laponite), and/or a cross-linking agent (such as a photo-initiator or chemical initiator), as well as powdered preparations of these, are also disclosed. Kits containing these preparations are provided for point-of-care tissue repair in vivo. Superior, more complete (up to 99.85% tissue regeneration within 4 weeks applied in situ), and rapid in situ tissue repair and bone formation are also demonstrated.
Type:
Grant
Filed:
July 30, 2019
Date of Patent:
May 9, 2023
Assignees:
The Texas A&M University System, The Board of Regents, The University of Texas System
Inventors:
Venu G. Varanasi, Azhar Ilyas, Philip Roger Kramer, Taha Azimaie, Pranesh B. Aswath, Tugba Cebe
Abstract: A method and system for performing biomolecule extraction are provided that use liquid-to-liquid extraction (LLE) in combination with an electrowetting on dielectric (EWOD) device to provide a biomolecule extraction solution that has high extraction efficiency and that is less costly and easier to use than current state of the art methods and systems. The system and method are well suited for, but not limited to, extraction of DNA, RNA and protein molecules.
Type:
Grant
Filed:
June 27, 2022
Date of Patent:
May 9, 2023
Assignee:
Board of Regents, The University of Texas System